Amany M. Fekry

2004–2010

A researcher in the Science corpus: 3 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Who trusts Amany M. Fekry overall

  1. S. Umoren
  2. B. D. Tiu

Papers from Amany M. Fekry's perspective

Ordered by how strongly the researchers Amany M. Fekry trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. (Clinical Infectious Diseases)
  2. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. (Clinical Infectious Diseases)
  3. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management (European Respiratory Journal)
  4. Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. (Clinical Infectious Diseases)
  5. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. (New England Journal of Medicine)
  6. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. (Clinical Infectious Diseases)
  7. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy… (Clinical Infectious Diseases)
  8. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial. (The Lancet)
  9. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. (New England Journal of Medicine)
  10. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. (Clinical Infectious Diseases)

Their papers